96 Line Were Actually Born In 2012

Lena Dunham: “I’m the Zodiac!”

stan a multitalented man (x)

Jacqueline Audry (1908-1977) was the first woman to make a career and enjoy commercial success as a film director in France. Her films often dealt with feminist themes and strong female characters, and were censored for their controversial depictions of politics and sexuality.

Her first feature film, Les malheurs de Sophie, was released in 1946, followed by three other films based on Collette novels. The 1951 film The Pit of Loneliness was perhaps her most controversial, heavily censored and restricted because of the portrayal of a lesbian relationship.

ONE OF THE MOST CRINGE-WORTHY SHIT I’VE EVER SEEN…

HOW CAN PEOPLE BE THIS BLARINGLY UNPROFESSIONAL!?!

IN THIS GENERATION!!! WHERE GOOGLE EXISTS!!!!

tune in next w

QUEENS !!!!

A century-old discovery of a virus could become our solution to antibiotic resistance 

Antibiotic resistance - the phenomenon in which bacteria stop responding to certain antibiotics - is a growing threat around the world.

It’s expected to kill 10 million people annually by 2050.

And it hasn’t been easy to develop new drugs in order to stay ahead of the problem. Many major pharmaceutical companies have stopped developing new antibiotics, and the drugs that are still in development have faced numerous stumbling blocks toward approval.

So some drugmakers are starting to turn to other solutions, including one that’s actually had a fairly long history: phage therapy.

The treatments are made of bacteria-killing viruses called bacteriophages, or phages for short. Discovered in the early 1900s, bacteriophages have the potential to treat people with bacterial infections.

They’re commonly used in parts of eastern Europe and the former Soviet Union as another way to treat infections that could otherwise be treated by antibiotics. Because they are programmed to fight bacteria, phages don’t pose much of a threat to human safety on a larger scale.

“There’s huge potential there that regular antibiotics don’t have,” NYT columnist Carl Zimmer told Business Insider in 2015. “I think what we’d actually have to work on is how we approve medical treatments to make room for viruses that kill bacteria.”